FDA inspection
Biocon Biologics Limited: FDA inspection ending Jul 26, 2024
FDA inspection 1245708 · Voluntary Action Indicated (VAI) · Bengaluru
Key facts
| Inspection ID | 1245708 |
|---|---|
| Firm | Biocon Biologics Limited |
| FEI number | 3003981475 |
| Address | Block No, B1,B2, B3, B5, Q13 Of Q1 And W20 & Unit S18,1st Floor, Block B4, Sez, Plot No.2,3,4&5, Phase Iv, Bommasandra-Jigani Link Road |
| City | Bengaluru |
| Country | India |
| Fiscal year | 2024 |
| Inspection end date | Jul 26, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data